Associations Between the Cyclic Guanosine Monophosphate Pathway and Cardiovascular Risk Factors: MESA

Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women

(2018) Di Zhao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Natriuretic Peptide Deficiency—When There Is Too Little of a Good Thing

(2018) Thomas J. Wang   JAMA Cardiology

Sex Hormones and Change in N-Terminal Pro-B-Type Natriuretic Peptide Levels: The Multi-Ethnic Study of Atherosclerosis

(2018) Wendy Ying et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Role of Phosphodiesterase 5 and Cyclic GMP in Hypertension

(2016) Evanthia Mergia et al.   CURRENT HYPERTENSION REPORTS

Higher BNP levels within physiological range correlate with beneficial nonfasting lipid profiles in the elderly: a cross-sectional study

(2016) Wen-Tao He et al.   Lipids in Health and Disease

Is enhancing cGMP-PKG signalling a promising therapeutic target for heart failure with preserved ejection fraction?

(2016) Á. Kovács et al.   Netherlands Heart Journal

N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) and Risk of Hypertension in the Atherosclerosis Risk in Communities (ARIC) Study

(2015) Julie K. Bower et al.   AMERICAN JOURNAL OF HYPERTENSION

The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment

(2015) M. Volpe et al.   CLINICAL SCIENCE

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

NH 2 -Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes

(2013) Mariana Lazo et al.   DIABETES

Riociguat for the Treatment of Pulmonary Arterial Hypertension

(2013) Hossein-Ardeschir Ghofrani et al.   NEW ENGLAND JOURNAL OF MEDICINE

The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction

(2013) Stephen J. Greene et al.   Journal of the American Heart Association

Activation of Heme Oxygenase and Suppression of cGMP Are Associated With Impaired Endothelial Function in Obstructive Sleep Apnea With Hypertension

(2012) Behrouz Jafari et al.   AMERICAN JOURNAL OF HYPERTENSION

Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction

(2012) Loek van Heerebeek et al.   CIRCULATION

Platelet nitric oxide signalling in heart failure: role of oxidative stress

(2011) Ashish Shah et al.   CARDIOVASCULAR RESEARCH

Purified Anthocyanin Supplementation Improves Endothelial Function via NO-cGMP Activation in Hypercholesterolemic Individuals

(2011) Y. Zhu et al.   CLINICAL CHEMISTRY

Myocardial Remodeling Is Controlled by Myocyte-Targeted Gene Regulation of Phosphodiesterase Type 5

(2010) Manling Zhang et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Hyperlipidaemia induced by a high-cholesterol diet leads to the deterioration of guanosine-3′,5′-cyclic monophosphate/protein kinase G-dependent cardioprotection in rats

(2009) Z Giricz et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cinaciguat (BAY 58–2667) Improves Cardiopulmonary Hemodynamics in Patients With Acute Decompensated Heart Failure

(2009) Harald Lapp et al.   CIRCULATION

The cyclic guanosine monophosphate/B-type natriuretic peptide ratio and mortality in advanced heart failure

(2009) Patrícia Lourenço et al.   EUROPEAN JOURNAL OF HEART FAILURE

Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics

(2009) Emily J. Tsai et al.   PHARMACOLOGY & THERAPEUTICS

Natriuretic Peptides in Chronic Kidney Disease

(2008) R. Tagore et al.   Clinical Journal of the American Society of Nephrology